课题基金 / 基金详情

项目摘要

项目成果

WILLIAM V GIANNOBILE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A major challenge in the reconstruction of tooth-supporting alveolar bone defects is the simultaneous restoration of bone, cementum and a functional periodontal ligament (PDL). To date, significant limitations exist with the predictability and extent of repair achievable via current regenerative periodontal therapies. We have demonstrated through the support of the NIDCR that gene therapy has strong potential to target and deliver growth-promoting factors (such as platelet-derived growth factor, bone morphogenetic proteins and LIM domain mineralization protein) to stimulate the re-engineering of periodontal defects. Further, by employment of emerging technologies in image-based scaffold design to address the complex topography of periodontal defects, we propose to employ customized biomimetic scaffolding strategies to repair periodontal wounds. The goal of this competitive renewal is to enhance novel gene delivery regenerative medicine strategies and apply them to relevant models of oral and periodontal disease. The specific aims of this proposal are: Specific Aim 1: Development of vector and image-based hybrid scaffolding constructs to repair tooth- supporting structures using ex vivo and in vivo models. Hypothesis: The controlled delivery of growth factor genes using computational design of hybrid scaffolds with fiber-oriented channels at the tooth-bone interface will stimulate and guide bone, ligament and cementum formation. A comparison of using direct versus reactive polymer coatings to facilitate growth factor gene delivery will be evaluated in vivo to repair periodontal defects. We will employ a bioconjugation process to functionalize biomaterials for the delivery of growth factors such as PDGF and BMPs to tissue engineer periodontia. Specific Aim 2: To use regional gene delivery methods via imaged-based scaffold design in experimental periodontal disease in canines. Hypothesis. The development of image-based scaffolds that can adapt to the tooth-bone interface and improve the bioavailability of growth factor genes at periodontal wound sites. We will utilize a ligature-induced model of periodontal disease to create periodontal osseous defects. We will then employ gene delivery technologies from SA #1 to use image-based hybrid scaffolds to promote periodontal repair. The results of these investigations should build on the body of evidence that our group has achieved in the field on periodontal tissue engineering. The findings from these investigations will well position us to apply this technology to the human clinical trial setting and submit a human clinical trial planning grant for a first-in-human investigation.
期刊论文(53)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/prd.12091
发表时间: 2015-06
期刊: Periodontology 2000
影响因子: 18.6
作者: [Sculean A, Chapple IL, Giannobile WV]
通讯作者: Giannobile WV
DOI: 10.1016/j.addr.2012.03.005
发表时间: 2012-09
期刊: ADVANCED DRUG DELIVERY REVIEWS
影响因子: 16.1
作者: [Pagni, G., Kaigler, D., Rasperini, G., Avila-Ortiz, G., Bartel, R., Giannobile, W. V.]
通讯作者: Giannobile, W. V.
DOI: 10.1007/978-1-60761-820-1_18
发表时间: 2010
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Seol YJ, Pellegrini G, Franco LM, Chang PC, Park CH, Giannobile WV]
通讯作者: Giannobile WV
DOI: 10.1038/gt.2011.203
发表时间: 2013-01
期刊: Gene therapy
影响因子: 5.1
作者: []
通讯作者:
32
    Harvard School of Dental Medicine Collaborative Clinical Practice-based REsearch Program for DENTal Schools (H-CREDENT)
    • 批准号:
      10754738
    • 项目类别:
    • 资助金额:
      $85.91万
    • 财政年份:
      2023
    • 负责人:
      WILLIAM V GIANNOBILE
    • 依托单位:
    Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation
    Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation
    Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation
    海外基金